Alfar chooses IBS Enterprise for pharmaceutical (IBS Pharma) to renew its core processes
Sep 09, 2010 Comments (0)
Alfar, which is currently undergoing a significant restructuring and core process review, was keen to apply industry best-practice processes, and replace its own 'home-made' solution which was no longer able to support the increasingly higher transaction demands and constant changes characteristic of today's market conditions. To that end Alfar chose high performing and state-of-the-art solutions from IBS.
Dott.ssa Caterina Tartara, Member of Alfar's Executive Board, commented: "We were looking for a reliable partner who understood the specific demands of pharmaceutical distribution, provided state-of-the-art technology, and could provide us with the confidence of a long-term partnership into the future. We evaluated some other possible solutions within Italian market and we chose IBS Pharma as 'the' solution and IBS FasTrax 'the' implementation methodology. FasTrax will enable us to speed up process development time, keep the costs under control, and take full advantage of all IBS Pharma functionalities. IBS' proven experience within distribution, and more specifically within the pharmaceutical market, inspires us with the confidence that we will gain great results from our process review."
Andy Bailey, Chief Marketing Officer IBS AB, said: "We are aware of the upmost importance of information systems such as ours within a firm such as Alfar. After all our systems run the business, and help ensure pharmaceutical distribution core requirement such as state-of-the-art customer service levels, 'around the clock' system availability, and 'open' customer communications, are delivered effectively. With pharmaceutical distribution being a key industry sector for IBS, Alfar's choice is another solid endorsement of our expertise and solution delivery in the sector"